1. Chuang, Yu-Hsuan, Lill, Christina M, Lee, Pei-Chen, Sinsheimer, Janet S, Ritz, Beate. 2016. Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2. In Neuroepidemiology, 47, 192-200. doi:10.1159/000450855. https://pubmed.ncbi.nlm.nih.gov/28135712/
2. Rahimi, Mohammad Rahman, Semenova, Ekaterina A, John, George, Generozov, Edward V, Ahmetov, Ildus I. 2024. Effect of ADORA2A Gene Polymorphism and Acute Caffeine Supplementation on Hormonal Response to Resistance Exercise: A Double-Blind, Crossover, Placebo-Controlled Study. In Nutrients, 16, . doi:10.3390/nu16121803. https://pubmed.ncbi.nlm.nih.gov/38931158/
3. Miao, Junxiao, Liu, Lu, Yan, Ci, Wang, Yuan, Zhu, Gang. 2019. Association between ADORA2A gene polymorphisms and schizophrenia in the North Chinese Han population. In Neuropsychiatric disease and treatment, 15, 2451-2458. doi:10.2147/NDT.S205014. https://pubmed.ncbi.nlm.nih.gov/31695381/
4. Tsujimoto, Shin-Ichi, Yanagimachi, Masakatsu, Tanoshima, Reo, Goto, Hiroaki, Ito, Shuichi. 2016. Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies. In Pediatric blood & cancer, 63, 1983-9. doi:10.1002/pbc.26090. https://pubmed.ncbi.nlm.nih.gov/27399166/
5. Oliveira, Sílvia, Ardais, Ana Paula, Bastos, Clarissa Ribeiro, Lara, Diogo Rizzato, Ghisleni, Gabriele. 2018. Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study. In Purinergic signalling, 15, 37-44. doi:10.1007/s11302-018-9635-2. https://pubmed.ncbi.nlm.nih.gov/30511252/
6. Yang, Qiuhua, Cai, Yongfeng, Ma, Qian, Sodhi, Akrit, Huo, Yuqing. 2024. Inactivation of adenosine receptor 2A suppresses endothelial-to-mesenchymal transition and inhibits subretinal fibrosis in mice. In Science translational medicine, 16, eadk3868. doi:10.1126/scitranslmed.adk3868. https://pubmed.ncbi.nlm.nih.gov/38446902/
7. Ran, Longyan, Mou, Xiao, Peng, Zhenglin, Sun, Xingwang, Yin, Tao. 2023. ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma. In Scientific reports, 13, 19477. doi:10.1038/s41598-023-46521-1. https://pubmed.ncbi.nlm.nih.gov/37945707/